TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01955252

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azithromycin
Description: Investigators will do a baseline survey of every children from 5 to 15 years in the village. To detect yaws infection, investigators will collect a blood specimen for serology (qualitative and quantitative RPR testing and TPHA assay).~Investigators will identify yaws-like ulcers by means of dermatological examination. Investigators will swab papilloma and ulcers and specimens will be flown to University of Washington (Seattle). PCR methods will consist of primary screening for the presence or absence of T. p. pertenue DNA, Haemophilus ducreyi DNA and detection of the A2058G and A2059G mutations associated with azithromycin resistance.~Investigators will begin treatment with antibiotics immediately after completion of the baseline survey. Everyone in the villages will be offered azithromycin, subsequently a field team will treat all active clinical cases and their contacts 6 monthly.~For all subjects, follow-up examination will be performed at 6,12,18,24,30,36,40,and 42 months
Study: NCT02946658

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: lipoaspiration
Description: Closed syringe harvesting subdermal fat

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ADcSVF
Description: Isolation of AD-cSVF

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Normal Saline IV
Description: Normal Saline IV containing AD-cSVF
Study: NCT00330434

Intervention type: OTHER
Group type: OTHER
Intervention: Trial Withdrawn 1
Description: Trial Withdrawn 1

Intervention type: OTHER
Group type: OTHER
Intervention: Trial Withdrawn 2
Description: Trial Withdrawn 2
Study: NCT04412512

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: VATS approach
Description: video-assisted thoracic surgery approach

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Thoracotomy approach
Study: NCT02874040

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoresection
Description: Endoresection of the tumor scar

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laser diode
Description: Transpupillary thermotherapy by laser diode on the tumor scar
Study: NCT02655120

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Drilling

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bone Marrow +BMP7
Study: NCT02650076

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SK-1405
Study: NCT00321620

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: zoledronic acid
Description: Q4W 4 mg zoledronic acid IV over minimum 15 minutes and 120 mg denosumab placebo SC

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: denosumab
Description: Q4W 120 mg denosumab SC and 4 mg zoledronic acid placebo IV over a minimum of 15 minutes
Study: NCT00905944

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Endurance exercise
Description: The patients carry out an exercise program (walking on a treadmill) three times weekly for 12 weeks at a speed corresponding with an intensity of 70% of VO2max.
Study: NCT00504660

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 6-Thioguanine
Description: Arms 1,2,3 = 80 mg/m\^2 PO Every 6 Hours on Day 1-3.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 6-Thioguanine
Description: Arms 1,2,3 = 80 mg/m\^2 PO Every 6 Hours on Day 1-3.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 6-Thioguanine
Description: Arms 1,2,3 = 80 mg/m\^2 PO Every 6 Hours on Day 1-3.
Study: NCT04330885

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supervised abdominal exercises and stationary biking
Description: Explain pain to the patients in order to minimize fear of movement
Study: NCT01011426

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bisacodyl
Description: 5mg po 6 hours postoperatively, repeat in 12 hours if no flatus

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: 1 capsule po 6 hours after surgery; repeat in 12 hours if no flatus
Study: NCT00706199

Intervention type: PROCEDURE
Intervention: Bone marrow aspiration
Description: Collection of a 2 ml bone marrow sample from an aspirate carried out for medical purposes.
Study: NCT03960307

Intervention type: OTHER
Intervention: Microcirculation and Glycocalyx assessment
Description: Non-invasive assessment of endothelial glycocalyx dimensions (PBR) and microcirculatory parameters (e.g. PPV, PVD, TVD, MFI)

Intervention type: OTHER
Intervention: Microcirculation and Glycocalyx assessment
Description: Non-invasive assessment of endothelial glycocalyx dimensions (PBR) and microcirculatory parameters (e.g. PPV, PVD, TVD, MFI)
Study: NCT00953407

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nelfilcon A contact lens
Description: Daily disposable contact lens worn in a daily wear, daily disposable mode

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Narafilcon A contact lens
Description: Daily disposable contact lens worn in a daily wear, daily disposable mode

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Etafilcon A contact lens
Description: Daily disposable contact lens worn in a daily wear, daily disposable mode

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Omafilcon A contact lens
Description: Daily disposable contact lens worn in a daily wear, daily disposable mode

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hilafilcon B contact lens
Description: Daily disposable contact lens worn in a daily wear, daily disposable mode
Study: NCT00446628

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: behaviors reducing spread of influenza
Description: Non-pharmaceutical interventions for flu prevention
Study: NCT02738736

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sodium Reduction
Description: In addition to usual care, those randomised to the intervention arm will receive specific counseling on behavioural and environmental factors that promote sodium reduction after randomization and at all specified post-randomisation visits, targeting sodium intake of \<100mmol/day (\<2.3g/day). A research dietitian will develop the specific components of the intervention, based on standardised approaches to education interventions
Study: NCT04236505

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) group based intervention
Description: 4 week ACT psychological intervention group based on Flaxman and McIntosh's ACT in the work place group format

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness based stress reduction (MBSR) informed brief mindfulness skills group intervention
Description: 4 week Mindfulness based stress reduction (MBSR) informed brief mindfulness skills group intervention

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Wait list Control group
Description: this group are placed on a wait list for group treatment whilst the other experimental groups run. This group are offered the MBSR based mindfulness skills once the follow up data has been collected from the other two experimental groups
Study: NCT02853838

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prolonged slow expiration+provoked coughing
Description: Five cycles of prolonged slow expiration and provoked coughing, which will be repeated five times.~During the prolonged slow expiration, the infant will be in supine while the therapist applies pressure at the same time on the rib cage and abdomen during spontaneous expiration. The pressure is applied slowly during two o three respiratory cycles, only during the final phase of expiration.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Manual chest wall vibration
Description: Five cycles of manual chest wall vibrations during 20 seconds each, being repeated five times.~The manual chest wall vibrations are oscillatory maneuvers applied on the thorax to improve mucociliary clearance of bronchial mucus and ease its removal.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Therapy
Description: Standard therapy (ST): nasopharyngeal suction, oxygen therapy, fluids administration, 0.5% adrenaline nebulization, and chest physiotherapy.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Therapy
Description: Standard therapy (ST): nasopharyngeal suction, oxygen therapy, fluids administration, 0.5% adrenaline nebulization, and chest physiotherapy.
Study: NCT02088307

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: CardioLife
Description: Participants randomized to treatment arm will take dietary supplement as instructed.
Study: NCT01597141

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family-aided Assertive Community Treatment
Description: The experimental treatment is a combination of family psychoeducation, assertive community treatment, supported education/employment and psychotropic medication.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced standard treatment
Description: In this arm, the subjects will receive the same psychotropic drugs, but will receive individual case management, family education and crisis intervention
Study: NCT06258460

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: psychotherapy training program intervention
Description: The intervention group will receive a two-day multimodal-based intensive educational intervention of CBT with 8 weeks follow-up (supervision based online teaching).

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: the wail-list control intervention
Description: The wail-list control group will receive a message encouraging them to complete all questionnaires from baseline to the last follow-up at 8 weeks.
Study: NCT01639495

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: THERMOCOOL® SMARTTOUCH™ Catheter
Description: AF Ablation
Study: NCT03290209

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic D1 Lymphadenectomy
Description: After exclusion of T4b, bulky lymph nodes, or distant metastasis case, laparoscopic D1 Lymphadenectomy will be performed in the experimental group.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic D2 Lymphadenectomy
Description: After exclusion of T4b, bulky lymph nodes, or distant metastasis case, laparoscopic D2 Lymphadenectomy will be performed in the comparator group.
Study: NCT02552641

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food effect

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food effect

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food effect

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esomeprazole

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esomeprazole

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esomeprazole

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clarythromycin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clarythromycin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clarythromycin
Study: NCT01466634

Intervention type: PROCEDURE
Intervention: percutaneous coronary intervention with stent
Description: patients with coronary artery disease treated by percutaneous coronary intervention with BP-DES are compared with patients with coronary artery disease treated by percutaneous coronary intervention with PP-DES

Intervention type: PROCEDURE
Intervention: percutaneous coronary intervention with stent
Description: patients with coronary artery disease treated by percutaneous coronary intervention with BP-DES are compared with patients with coronary artery disease treated by percutaneous coronary intervention with PP-DES
Study: NCT02634957

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: absolute voice rest
Description: absolute voice rest is the complete elimination of any vocalization (no sounds, speaking or whispering)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: absolute voice rest
Description: absolute voice rest is the complete elimination of any vocalization (no sounds, speaking or whispering)
Study: NCT02490098

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin
Description: Participant's usual fast-acting insulin analog will be used: Lispro (Humalog), Aspart (NovoRapid) or Glulisine (Apidra)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin
Description: Participant's usual fast-acting insulin analog will be used: Lispro (Humalog), Aspart (NovoRapid) or Glulisine (Apidra)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glucagon
Description: Glucagon (Eli Lilly) will be used during dual-hormone closed-loop strategy.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glucagon
Description: Glucagon (Eli Lilly) will be used during dual-hormone closed-loop strategy.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Continuous Glucose Monitoring System Enlite sensor®, Medtronic
Description: Enlite sensor®, Medtronic

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Continuous Glucose Monitoring System Enlite sensor®, Medtronic
Description: Enlite sensor®, Medtronic

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Continuous Glucose Monitoring System Enlite sensor®, Medtronic
Description: Enlite sensor®, Medtronic

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Continuous Glucose Monitoring System Enlite sensor®, Medtronic
Description: Enlite sensor®, Medtronic

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Continuous Glucose Monitoring System Enlite sensor®, Medtronic
Description: Enlite sensor®, Medtronic

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Insulin pump MiniMed® Paradigm® Veo™, Medtronic
Description: MiniMed® Paradigm® Veo™, Medtronic
Study: NCT03650517

Intervention type: PROCEDURE
Intervention: Extracorporeal Anastomosis
Description: Anastomosis is performed by pulling out the bowel through a laparotomy wherever that laparotomy is performed.

Intervention type: PROCEDURE
Intervention: Extracorporeal Anastomosis
Description: Anastomosis is performed by pulling out the bowel through a laparotomy wherever that laparotomy is performed.

Intervention type: PROCEDURE
Intervention: Intracorporeal Anastomosis
Description: Anastomosis is performed inside the abdominal cavity with a laparoscopic or robotic technique

Intervention type: PROCEDURE
Intervention: Intracorporeal Anastomosis
Description: Anastomosis is performed inside the abdominal cavity with a laparoscopic or robotic technique

Intervention type: PROCEDURE
Intervention: Robotic Surgery
Description: Procedure is performed using robotic instruments

Intervention type: PROCEDURE
Intervention: Robotic Surgery
Description: Procedure is performed using robotic instruments

Intervention type: PROCEDURE
Intervention: Laparoscopic Surgery
Description: Procedure is performed using standard laparoscopic instruments

Intervention type: PROCEDURE
Intervention: Laparoscopic Surgery
Description: Procedure is performed using standard laparoscopic instruments
Study: NCT03823560

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Celegyn®
Description: Medical device Celegyn® presents itself as a cream.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Matching placebo
Description: IP placebo presents itself as a cream.
Study: NCT01824160

Intervention type: DEVICE
Group type: OTHER
Intervention: Repair of RV-PA Conduit Disruption
Description: Repair of RV-PA Conduit Disruption
Study: NCT06284148

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Screening for intimate partner violence
Description: confidential screening using exam computer

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Screening for intimate partner violence
Description: confidential screening using exam computer

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Screening for intimate partner violence
Description: confidential screening using exam computer

Intervention type: OTHER
Group type: OTHER
Intervention: Assessment and referral
Description: confidential assessment and referral of high-risk patients using decision-support templates

Intervention type: OTHER
Group type: OTHER
Intervention: Assessment and referral
Description: confidential assessment and referral of high-risk patients using decision-support templates

Intervention type: OTHER
Group type: OTHER
Intervention: Assessment and referral
Description: confidential assessment and referral of high-risk patients using decision-support templates
Study: NCT02490098

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Insulin pump MiniMed® Paradigm® Veo™, Medtronic
Description: MiniMed® Paradigm® Veo™, Medtronic

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Insulin pump MiniMed® Paradigm® Veo™, Medtronic
Description: MiniMed® Paradigm® Veo™, Medtronic

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Insulin pump MiniMed® Paradigm® Veo™, Medtronic
Description: MiniMed® Paradigm® Veo™, Medtronic
Study: NCT02838433

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: biological samples
Description: blood and tissue samples
Study: NCT04568460

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention Group Sessions
Description: Participants will undergo a multi-session group intervention over the course of six months.
Study: NCT01617304

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Description: Food made by different cooking methods (boiling/steaming versus frying) and with glucose or fructose water solution

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Description: Food made by different cooking methods (boiling/steaming versus frying) and with glucose or fructose water solution

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Description: Food made by different cooking methods (boiling/steaming versus frying) and with glucose or fructose water solution

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Description: Food made by different cooking methods (boiling/steaming versus frying) and with glucose or fructose water solution
Study: NCT04040816

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAP-001
Description: SAP-001 or placebo treatment in a 4:1 randomization ratio

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAP-001
Description: SAP-001 or placebo treatment in a 4:1 randomization ratio

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAP-001
Description: SAP-001 or placebo treatment in a 4:1 randomization ratio

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SAP-001
Description: SAP-001 or placebo treatment in a 4:1 randomization ratio
Study: NCT00111527

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Optimized echo-guided CRT pacing
Description: Echo-TDI guided VV-delay optimization

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: normal RV pacing
Description: PM or ICD implant according to patient indication
Study: NCT00889317

Intervention type: DEVICE
Intervention: fmri (functional magnetic resonance imaging)
Description: functional image acquisition (75mn) anatomical image acquisition (15mn)
Study: NCT02709915

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Breakfast Diet (Bdiet)
Description: The Breakfast Ddiet consist of high-energy breakfast, medium-sized lunch and reduced in energy dinner, with distribution of calories: breakfast 50%, lunch 33% and dinner 17%. In this diet, the investigators will evaluate at baseline and at the end of 12 weeks of diet intervention, the diet efficacy on reducing HbA1c, the total daily insulin dose requirements (TDID), the efficacy on reducing body weight, fasting plasma glucose (FPG) and overall glycemic excursion assessed with continuous monitoring system. The investigators will assess also the Clock Genes mRNA expression in white blood cells. at baseline and after 12 weeks of diet intervention

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Breakfast Diet (Bdiet)
Description: The Breakfast Ddiet consist of high-energy breakfast, medium-sized lunch and reduced in energy dinner, with distribution of calories: breakfast 50%, lunch 33% and dinner 17%. In this diet, the investigators will evaluate at baseline and at the end of 12 weeks of diet intervention, the diet efficacy on reducing HbA1c, the total daily insulin dose requirements (TDID), the efficacy on reducing body weight, fasting plasma glucose (FPG) and overall glycemic excursion assessed with continuous monitoring system. The investigators will assess also the Clock Genes mRNA expression in white blood cells. at baseline and after 12 weeks of diet intervention

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 6Meal Diet (6Mdiet
Description: The 6meal diet (6Mdiet) will consist in the traditional antidiabetic diet, consuming 6 small meals: breakfast, lunch and dinner and 3 snacks, with caloric distribution: breakfast 20%, lunch 25%, dinner 25% and 10% each of the 3 snacks. In this diet, the investigators will evaluate at the beginning and at the end of the study (12 weeks), the diet effects on reducing HbA1c, total daily insulin dose requirements (TDID), and the diet efficacy on reducing body weight, fasting plasma glucose (FPG) and overall glycemic excursion, using continuous monitoring system, The investigators will assess also at baseline and at the end of the diet intervention the Clock Genes mRNA expression in white blood cells.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 6Meal Diet (6Mdiet
Description: The 6meal diet (6Mdiet) will consist in the traditional antidiabetic diet, consuming 6 small meals: breakfast, lunch and dinner and 3 snacks, with caloric distribution: breakfast 20%, lunch 25%, dinner 25% and 10% each of the 3 snacks. In this diet, the investigators will evaluate at the beginning and at the end of the study (12 weeks), the diet effects on reducing HbA1c, total daily insulin dose requirements (TDID), and the diet efficacy on reducing body weight, fasting plasma glucose (FPG) and overall glycemic excursion, using continuous monitoring system, The investigators will assess also at baseline and at the end of the diet intervention the Clock Genes mRNA expression in white blood cells.
Study: NCT02490098

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Insulin pump MiniMed® Paradigm® Veo™, Medtronic
Description: MiniMed® Paradigm® Veo™, Medtronic
Study: NCT03773224

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Irrigation
Description: upon closure of the peritoneum gentamicin-saline solution (160 mg of gentamicin in 400 ml of normal saline 0.9%) will be used for irrigation of every layer of the wound before its closure